SCHEMBL19009538

SCHEMBL19009538

CCc1ccc(-c2nc(-c3ccc(CC)cc3)nc(-c3cccc(-c4cccc(-c5ccnc6ccccc56)c4)c3)n2)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPKAPK2 P49137 1/20 0.47
ACVR1 Q04771 7/20 0.45
KDR P35968 1/20 0.43
AAK1 Q2M2I8 2/20 0.42
PIK3CA P42336 1/20 0.41
CYP1A2 P05177 1/20 0.40
PDE7A Q13946 2/20 0.39
PDE7B Q9NP56 2/20 0.39
CA12 O43570 1/20 0.38
CA1 P00915 1/20 0.38
CA2 P00918 1/20 0.38
CA9 Q16790 1/20 0.38
KDM4E B2RXH2 1/20 0.38
ALDH1A1 P00352 1/20 0.38
HPGD P15428 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
WNT3A P56704 1/20 0.38
CAMKK1 Q8N5S9 1/20 0.38
CAMKK2 Q96RR4 1/20 0.38
AURKA O14965 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21131513 0.84 ACVR1 (0.49) ACVR1AAK1PIK3CACYP1A2KDM4E
SCHEMBL17343301 0.83 ACVR1 (0.48) ACVR1AAK1PIK3CACYP1A2CA12
SCHEMBL17343258 0.80 PIK3CA (0.51) ACVR1PIK3CACYP1A2CA12CA1
SCHEMBL17932567 0.80 TSHR (0.48) ACVR1PIK3CACYP1A2
SCHEMBL19762202 0.80 L3MBTL1 (0.47) MAPKAPK2CYP1A2KDM4EALDH1A1HPGD
SCHEMBL17343216 0.79 CYP1A2 (0.50) ACVR1PIK3CACYP1A2KDM4EALDH1A1
SCHEMBL12580413 0.78 PIK3CA (0.54) ACVR1KDRPIK3CACYP1A2CA12
SCHEMBL12580359 0.78 PIK3CA (0.54) ACVR1KDRPIK3CACYP1A2CA12
SCHEMBL21131858 0.78 PIK3CA (0.52) ACVR1AAK1PIK3CACYP1A2KDM4E
SCHEMBL17720955 0.78 CA12 (0.52) ACVR1PIK3CACA12CA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11329230-B2 Organic light-emitting device SAMSUNG DISPLAY CO., LTD. (KR) 2022-05-10 US disclosed
US-20170317294-A1 ORGANIC LIGHT-EMITTING DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2017-11-02 US disclosed
US-20170317294-A1 ORGANIC LIGHT-EMITTING DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2017-11-02 US disclosed
US-20170179402-A1 ORGANIC LIGHT-EMITTING DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2017-06-22 US disclosed
US-20170179402-A1 ORGANIC LIGHT-EMITTING DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2017-06-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11329230-B2 Organic light-emitting device EML4, SUN2, TRPA1 MAPKAPK2 2539/4885ACVR1 2235/4885KDR 1355/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.